Fig. 5
Cumulative incidence of breast cancer recurrence or death of tamoxifen (Tam) alone vs tamoxifen plus fluoxymesterone (Tam + Flu) in patients with AR-enriched, ER-enriched tumors (A) and AR-poor to moderate, ER-enriched tumors (B)
Fig. 5 | Breast Cancer Research